ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Alumis at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Alumis brings 2 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 3933. Its program centres on envudeucitinib, a TYK2 inhibitor, covering Phase 3 results in plaque psoriasis and its effect on lupus-related interferon markers in skin.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
Alumis South San Francisco, CA | |
A biotechnology company developing targeted therapies for immune-mediated diseases. | Booth Exhibiting at Booth 3933 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Mon Nov 9 10:30am–12:30pm |
Find decision makers at Alumis
Tell us what you sell and we’ll find the people at Alumis most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction